Humanoid Robots Have Entered the Operating Room
General-purpose humanoids have demonstrated preclinical surgical feasibility, but teleoperation is not autonomy.
Read this GVC →Grains of Vital Cognizance by Georgi V. Chaltikyan
GVCs
One consequential development. One evidence-led thesis. One question that invites a better conversation.
Latest entries
194 Years? A Biological Model—Not a Longevity Promise
A theoretical ceiling can guide science—but it is not evidence that humans can reach it.
Read this GVC →
AI Is Becoming a Commercial Determinant of Health
AI is not only changing healthcare. It is changing how commercial power shapes health.
Read this GVC →
21% Fewer Deaths — and Still 1.16 Million Lost
Road-safety progress is real. The toll remains intolerable.
Read this GVC →
AI4H Sovereignty
Medical AI should be contextualised, validated and governed within the health system where it will be used.
Read this GVC →
Can Medical AI Forget?
Deleting patient data may not remove its influence from a trained medical AI model.
Read this GVC →
From Device to Care
Connected health is moving from monitoring toward clinical care and outcome-aligned payment.
Read this GVC →
No Automation Without Representation
Frontline clinicians need a real voice in how clinical AI is used.
Read this GVC →
One Trillion Minutes
One wearable foundation model transferred across 35 health-prediction tasks.
Read this GVC →
Younger—But Biologically Older
Later-born generations show greater biological ageing and a higher observed risk of early-onset cancer.
Read this GVC →
Evidence First
Traditional medicine must meet the same standards of efficacy and safety as every other intervention.
Read this GVC →
Protect the Craft
AI training on surgical expertise requires consent, transparency, ownership, and control.
Read this GVC →
Perverse Incentives
Health systems need incentives that reward prevention, outcomes, and long-term health.
Read this GVC →
Retraining
Physicians will increasingly need to act as scientific interpreters rather than protocol-followers.
Read this GVC →
A Blood Signature for Lung Cancer Risk
A 14-protein panel may identify elevated lung-cancer risk more than five years before diagnosis.
Read this GVC →
The $1.2 Quadrillion Opportunity
The economic value of extended healthspan could be enormous—but access will determine who benefits.
Read this GVC →
Who Drives Healthcare Costs?
A US survey finds that 81% of respondents identify corporate health insurers as the greatest influence.
Read this GVC →
RISE
Equitable AI for Health requires capacity, inclusive research, accessible infrastructure, and secure data practices.
Read this GVC →
AI Arms Race
When providers use AI to code and payers use AI to deny, the system may automate mistrust faster than care.
Read this GVC →
UK Biobank Data Leak
The exposure of participants’ medical details is a warning shot for health-data governance.
Read this GVC →
Financial Toxicity of Cancer
Cancer can carry severe financial consequences, including markedly higher bankruptcy risk and lower credit scores.
Read this GVC →
77 Cents for Biomedical Data
The gap between AI investment and sustained biomedical-data investment remains extraordinary.
Read this GVC →